by admin_63069 | Jan 20, 2025 | News You Can Use
Findings from a recent study show that PSMA-PET may have diagnostic value in the initial staging of patients with intermediate- and high-risk prostate cancer.
by admin_63069 | Jan 15, 2025 | Related Topics, Uncategorized
Is it safe to omit biopsy following negative magnetic resonance imaging (MRI) results in men with clinically suspected prostate cancer?
by admin_63069 | Jan 14, 2025 | Resources
Managing advanced prostate cancer
by admin_63069 | Jan 13, 2025 | News You Can Use
The National Comprehensive Cancer Network (NCCN) has endorsed the Prolaris prostate cancer prognostic test, reinforcing its position as a critical tool in prostate cancer prognostication.
